Related Experiment Video
Updated: Apr 2, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Evaluation and management of premenstrual dysphoric disorder
Shea A Nagle1, Pamela J Murray1,2, Emily B Allen3,4
1Division of Adolescent and Young Adult Medicine, Boston Children's Hospital.
Insights
Premenstrual dysphoric disorder (PMDD) diagnosis and treatment can be challenging, especially for diverse populations. This review offers pediatricians practical guidelines for evaluating and managing PMDD, considering recent research and emerging treatment options.
Area of Science:
- Reproductive Psychiatry
- Pediatric Gynecology
- Mental Health
Background:
- Premenstrual dysphoric disorder (PMDD) significantly impacts quality of life.
- Diagnostic delays are common, hindering timely treatment initiation.
- Challenges in care access and diagnosis are noted, particularly for marginalized groups.
Purpose of the Study:
- To review current evidence for evaluating and treating PMDD.
- To provide practical guidelines for pediatric providers.
- To address special considerations for diverse patient populations.
Main Methods:
- Literature review of recent research on PMDD evaluation and treatment.
- Synthesis of evidence relevant to pediatric care.
- Focus on pathophysiology, current treatments, and future management.
Main Results:
- Difficulties in patient presentation, diagnosis, and treatment for PMDD are highlighted.
- Comorbid mental health disorders and marginalized identities can exacerbate challenges.
- Established treatments include SSRIs and oral contraceptive pills; new insights into pathophysiology and treatments are emerging.
Conclusions:
- Provides practical guidelines for pediatricians on PMDD evaluation and management.
- Emphasizes the need for special considerations for diverse populations.
- Aims to improve care for pediatric patients with PMDD.
Purpose Of Review:
Premenstrual dysphoric disorder (PMDD) is a condition that impacts the quality of life of those affected. Diagnosis can be difficult and lead to delays in treatment. In this article, we review current evidence for the evaluation and treatment of PMDD relevant to pediatric providers and their patients.
Recent Findings:
Recent research emphasizes the difficulties that patients with PMDD face in presenting to care and receiving appropriate diagnosis and treatment. Some of these challenges appear to be exacerbated among populations with comorbid mental health disorders and/or marginalized identities. While there are longstanding data supporting the use of selective serotonin-reuptake inhibitors and oral contraceptive pills in managing PMDD, emerging research provides insight on disease pathophysiology, mechanisms of action for current treatments, and potential horizons for new management options.
Summary:
This article aims to provide practical guidelines for pediatricians to use in the initial evaluation and management of PMDD with special considerations for diverse populations.
More Related Videos
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Disorders of the Female Reproductive System
Mitral Valve Prolapse II: Assessment and Management
Antidepressant Drugs: MAOIs and Other Agents
Dysrhythmias VII: Nursing Management of Dysrhythmias
Mania and Antimanic Drugs: Overview

